Axinn Represents Thermo Fisher in $1.3B Acquisition of Affymetrix
January 11, 2016
Axinn is representing Thermo Fisher Scientific Inc. in its $1.3 billion acquisition of Affymetrix, a leading provider of cellular and genetic analysis products. The Axinn team consists of John Harkrider, Mark Alexander and Kail Jethmalani.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
Consumer Brands CPG Legal Forum 2025
Speaking Engagement
Antitrust
Noerr Competition Day 2025
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Working the Headline-Grabbing Antitrust Cases as a Junior Associate with Axinn: Google Ad Tech
Speaking Engagement
Axinn Participates in Diversity Lab’s Counsel Spotlight
Diversity, Equity & Inclusion
USITC Commissioner Series: Commissioner Schmidtlein is Stepping Down, Which Could Lead to More Tailored Exclusion Orders
Axinn Viewpoints
Intellectual Property